Page last updated: 2024-12-05

propiolic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Propiolic acid, also known as 3-propynoic acid, is a highly reactive organic compound with a triple bond between the second and third carbon atoms. It is a colorless liquid with a pungent odor.

**Synthesis:** Propiolic acid can be synthesized through various methods, including:
* **Reaction of acetylene with carbon dioxide in the presence of a catalyst:** This is a common method for industrial-scale production.
* **Dehydration of tartaric acid:** This method involves heating tartaric acid in the presence of a dehydrating agent.
* **Reaction of propiolic acid derivatives with strong acids:** This method involves the use of propiolic acid esters or amides as starting materials.

**Effects:** Propiolic acid is a strong acid with a pKa of 1.8. It is also a highly reactive compound that can undergo various reactions, including:
* **Nucleophilic addition:** The triple bond in propiolic acid can react with nucleophiles, such as alcohols and amines, to form adducts.
* **Cycloaddition:** Propiolic acid can participate in cycloaddition reactions with dienes, forming cyclic compounds.
* **Polymerization:** Propiolic acid can polymerize under certain conditions to form polypropargyl polymers.

**Importance and Research:** Propiolic acid is of significant interest in various fields, including:
* **Organic synthesis:** It is a versatile building block for the synthesis of various organic compounds, including pharmaceuticals, agrochemicals, and polymers.
* **Materials science:** Propiolic acid and its derivatives are used in the production of polymers, resins, and adhesives with unique properties.
* **Medicinal chemistry:** Some derivatives of propiolic acid have shown potential as antibacterial, antifungal, and anticancer agents.

**Why it is studied:**
* **Highly reactive nature:** Its highly reactive triple bond makes it a valuable synthetic intermediate for various reactions.
* **Potential applications:** Propiolic acid and its derivatives have potential applications in a wide range of fields, including materials science, medicinal chemistry, and organic synthesis.
* **Understanding its chemistry:** Research on propiolic acid helps to better understand its chemical properties and reactivity, which is crucial for its safe and efficient use in various applications.'

propiolic acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

propynoic acid : A terminal acetylenic compound that is a 3-carbon, straight-chain, monounsaturated fatty acid having one acetylenic bond. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10110
CHEMBL ID1213530
CHEBI ID33199
MeSH IDM0057897

Synonyms (46)

Synonym
CHEMBL1213530
hc#ccooh
propinsaeure
propiolsaeure
CHEBI:33199 ,
prop-2-ynoic acid
propinic acid
hc.equiv.ccooh
nsc 16152
einecs 207-437-8
propynoic acid
2-propynoic acid
propargylic acid
nsc-16152
nsc16152
carboxyacetylene
acetylenecarboxylic acid
propiolic acid
471-25-0
C00804
propiolic acid, 95%
P0497
AKOS000121542
BBL011346
STL146436
p2qw39g9lz ,
hsdb 7857
unii-p2qw39g9lz
2-propyne-1-carboxylic acid
acetylenemonocarboxylic acid
propiolic acid [mi]
S6108
acetylene carboxylic acid
DTXSID6060050
STR03210
hc.$.ccooh
mfcd00004360
F2191-0185
propiolic acid, technical, >=95% (t)
BCP18740
Q257590
AMY7000
F10329
26969-44-8
EN300-21202
Z104493798

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" In our continuing efforts to identify small molecule alpha(V)beta(3) and alpha(V)beta(5) dual antagonists, we recently reported indoles 2-4 as potent and selective alpha(V)beta(3)/alpha(V)beta(5) antagonists with good oral bioavailability profile."( Novel potent and selective alphavbeta3/alphavbeta5 integrin dual antagonists with reduced binding affinity for human serum albumin.
Chaikin, M; Crysler, C; Lattanze, J; Leonard, K; Manthey, CL; Marugán, JJ; Pan, W; Raboisson, P; Tomczuk, BE, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
acetylenic fatty acidAny unsaturated fatty acid containing at least one triple bond in the carbon chain framework.
monounsaturated fatty acidAny fatty acid with one double or triple bond in the fatty acid chain and singly bonded carbon atoms in the rest of the chain. MUFAs have positive effects on the cardiovascular system, and in diabetes treatment.
short-chain fatty acidAn aliphatic monocarboxylic acid with a chain length of less than C6. If any non-hydrocarbon substituent is present, the compound is not normally regarded as a short-chain fatty acid.
terminal acetylenic compoundAn acetylenic compound which a carbon of the C#C moiety is attached to a hydrogen atom.
alpha,beta-unsaturated monocarboxylic acidA monocarboxylic acid in which the carbon of the carboxy group is directly attached to a C=C or C#C bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Propanoate metabolism ( Propanoate metabolism )2222
NAD+ + 2-Propyn-1-al + H2O = NADH + Propiolic acid ( Propanoate metabolism )74

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1432754Time-dependent Sporosarcina pasteurii CCM 2056 urease assessed as reduction in ammonia production using urea as substrate by phenol-hypochlorite method2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID1432755Competitive inhibition of Sporosarcina pasteurii CCM 2056 urease assessed as reduction in ammonia production preincubated with enzyme followed by addition of varying levels of urea as substrate measured for 120 mins by Lineweaver-Burk plot analysis2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID498775Toxicity in po dosed mouse2009Nature chemical biology, Jul, Volume: 5, Issue:7
Identification of the toxic trigger in mushroom poisoning.
AID1432760Inhibition of Sporosarcina pasteurii CCM 2056 urease assessed as reduction in ammonia production by measuring steady state enzyme-inhibitor complex using urea as substrate measured for 120 mins by phenol-hypochlorite method2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID1432756Reversible inhibition of Sporosarcina pasteurii CCM 2056 urease assessed as reduction in ammonia production by measuring recovery of enzyme activity at 10 times IC50 preincubated for 60 mins followed by 100-fold dilution in to PBS containing urea as subst2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID1432759Inhibition of Sporosarcina pasteurii CCM 2056 urease assessed as reduction in ammonia production by measuring initial state enzyme-inhibitor complex using urea as substrate measured for 120 mins by phenol-hypochlorite method2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID1432751Inhibition of Sporosarcina pasteurii CCM 2056 urease assessed as reduction in ammonia production using urea as substrate measured for 120 mins by phenol-hypochlorite method2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (70)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (2.86)18.7374
1990's0 (0.00)18.2507
2000's28 (40.00)29.6817
2010's37 (52.86)24.3611
2020's3 (4.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.25 (24.57)
Research Supply Index4.28 (2.92)
Research Growth Index4.35 (4.65)
Search Engine Demand Index73.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (4.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other68 (95.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]